In lung cancer, DCBLD2 has been shown to be highly upregulated in the cell line NCI-H460-LNM35, in association with its acquisition of metastatic phenotype, and also upregulated in high frequency in metastatic lesions from lung cancers (Koshikawa et al, 2002). Here, DCBLD2 is linked to lung carcinoma.